AN2 TherapeuticsANTX
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 31 institutions reported holding AN2 Therapeutics Inc. (ANTX) in their 13F filings, down 14 from Q2 2024. 8 opened new positions and 22 sold out. The largest holders were BML Capital Management, LLC ($6.2M), Ra Capital Management, L.P. ($2.1M) and TCG Crossover Management, LLC ($1.7M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- AN2 Therapeutics Inc.
- CUSIP
- 037326105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $6.9M |
| Exits | 22 | $19.9M |
All 13F filers, Q2 2024 → Q3 2024: 7,122,724 shares bought and 13,026,882 shares sold, net −5,904,158 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| BML Capital Management, LLC | 3.62% | New | 5,749,432 | $6.2M |
| Ra Capital Management, L.P. | 0.02% | Reduce -64.0% | 1,999,997 | $2.1M |
| TCG Crossover Management, LLC | 0.14% | No change | 1,555,118 | $1.7M |
| Vanguard Group Inc. | 0.00% | No change | 1,041,527 | $1.1M |
| Acuitas Investments, LLC | 0.21% | New | 445,783 | $477K |
| Renaissance Technologies | 0.00% | Add +2863.6% | 423,800 | $453K |
| Millennium Management | 0.00% | Reduce -24.4% | 397,925 | $426K |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 312,615 | $334K |
| BlackRock, Inc. | 0.00% | — | 301,176 | $322K |
| Geode Capital Management, LLC | 0.00% | Add +21.7% | 220,162 | $236K |
| Bridgeway Capital Management, LLC | 0.00% | Add +88.9% | 197,000 | $211K |
| Two Sigma Investments, LP | 0.00% | Add +34.6% | 177,840 | $190K |
| Two Sigma Advisers, LP | 0.00% | Reduce -10.2% | 120,900 | $129K |
| Aldebaran Capital, LLC | 0.10% | New | 100,500 | $108K |
| Jacobs Levy Equity Management, Inc. | 0.00% | New | 79,359 | $85K |
| Schonfeld Strategic Advisors LLC | 0.00% | Add +203.6% | 66,100 | $71K |
| Marquette Asset Management, LLC | 0.01% | New | 64,503 | $69K |
| State Street Corp. | 0.00% | No change | 60,302 | $65K |
| Acadian Asset Management LLC | 0.00% | Reduce -51.3% | 42,335 | $45K |
| Northern Trust Corp. | 0.00% | No change | 32,595 | $35K |
| Captrust Financial Advisors | 0.00% | No change | 28,667 | $31K |
| Integrated Wealth Concepts LLC | 0.00% | New | 25,000 | $27K |
| XTX Topco Ltd | 0.00% | New | 23,659 | $25K |
| Private Advisor Group, LLC | 0.00% | No change | 22,500 | $24K |
| Bank of America Corp. | 0.00% | Add +3.7% | 16,210 | $17K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -21.3% | 4,256 | $5K |
| Federated Hermes, Inc. | 0.00% | Add +227.8% | 3,006 | $3K |
| Morgan Stanley | 0.00% | Reduce -98.3% | 303 | $324 |
| FMR LLC | 0.00% | New | 300 | $321 |
| Osaic Holdings, Inc. | 0.00% | No change | 300 | $321 |
| JPMorgan Chase & Co. | 0.00% | Reduce -94.7% | 54 | $58 |
"% of holder's portfolio" is ANTX's weight in each manager's 13F, not the share of AN2 Therapeutics Inc. the manager owns.